BioNtech and Pfizer to supply 120 million doses of vaccine to Japan.
Image Credit: EP News Bureau
On Friday, Pfizer and BioNtech agreed to supply Japan with 120 million doses of their experimental vaccine in the first half of 2021. No financial details have been released yet, but the terms of the agreement are based on the volume of doses and timing of delivery.
United States have also signed a deal with Pfizer and BioNtech for the delivery of 100 million doses for $2 billion. This is equal to $39 per dose. It has been reported The that it is most likely a two dose treatment. Both companies aim that by the end of 2020, they will have 100 million doses ready and 1.3 billion doses by the end of 2021.
Earlier this week both companies begun a phase 2b/3 safety and efficacy trial of their vaccine, and they aim to submit the results for reviewing on October.
Japan has been recently hit a surge in coronavirus cases, especially in Tokyo. As of today Japan had 33,049 cases and 1,004 deaths.